Development and Validation of a Novel Gene Signature for Predicting the Prognosis of Idiopathic Pulmonary Fibrosis Based on Three Epithelial-Mesenchymal Transition and Immune-Related Genes.

Front Genet · 2022 · PMC9086533 · PMID 35559024

Europe PMC DOI

hedged sentence

0.0150

closest p · 0.3× alpha

0.0150

boldest claim

The sentences

markedly significantp = 0.015actually significant

Pleasingly, the difference of survival between these two groups was markedly significant ( p = 0.015), and the prognosis of patients in the immune score-high group was worse than that in the immune score-low group ( Figure 3D ).

also in 476 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.